The Part A Pharmacy Report
Who pays for drugs during a Medicare Part A nursing home stay, what it costs New York facilities, and how to check the bill.
Inside this report
- 1Executive summaryFive numbers every New York operator should know
- 2The New York marketFacilities, beds, ownership and who runs them
- 3Where the Part A days areMedicare Part A volume by facility and region
- 4What Part A drugs cost New York facilitiesA transparent estimate, with the method shown
- 5The rulesConsolidated billing, exclusions, discharge and leave of absence
- 6The riskThe OIG audit and the open Work Plan project
- 7What overbilling looks likeThe categories, and where each one hides
- 8The 20-point invoice checklist
- 9Ten contract terms to checkIn your pharmacy services agreement
- 10A 90-day planWhat to do this quarter, in order
- 11Methodology and sources
- 12About Pennywell
How this report was built
Pennywell has no client data to draw on yet, so this report uses only public sources. Facility counts, beds and ownership come from the CMS nursing home files (October 2026 release). Medicare Part A day counts come from the CMS Post-Acute Care public use file for fiscal year 2024. Payer mix comes from CMS cost report data. The rules come from the Code of Federal Regulations, CMS manuals and OIG publications.
Where we estimate dollars, we say so, label it Pennywell estimate, and show the inputs. Figures taken directly from a public source carry Public data. We report aggregates only. No facility, owner or resident is named.
General information, not legal or billing advice. Facilities make their own compliance and dispute decisions and should consult counsel on specific situations. Pennywell takes no money from pharmacies or drug manufacturers.
Executive summary
During a covered Medicare Part A stay, the nursing home pays for the resident's drugs out of a fixed daily rate. In New York that obligation runs to millions of days a year, and regulators are now checking whether facilities meet it.
New York nursing homes, with 111,253 certified beds Public data
Average occupancy is 88.9%. 70.3% are for-profit. The median building has 160 beds.
CMS Provider Information, October 2026 releaseOriginal Medicare Part A days in New York, fiscal year 2024 Public data
Across 131,576 stays. Each day is one on which the facility, not Part D, owes for the resident's drugs. New York accounts for 10.3% of the national total.
CMS Post-Acute Care PUF, SNF by provider, fiscal year 2024Facility-paid Part A drug spend a year Pennywell estimate
Part A days times $40–$48 per Part A resident-day, the range one operator reported publicly. Excludes Medicare Advantage. Method in section 4.
CMS PAC PUF; Becker's Hospital Review (operator-reported 2017–2018 range)Of New York facilities are run by operators with 15 or fewer buildings Public data
409 of 592. 49.2% have no CMS chain affiliation at all. Most have no corporate audit team checking the pharmacy bill.
CMS Provider Information and Ownership files; Pennywell operator groupingImproper Part D payments for drugs Part A should have covered, 2018–2020 National
The OIG's estimate in audit A-09-21-03008. In April 2025 it opened a follow-on project on facilities' own financial responsibility for those drugs.
HHS OIG, A-09-21-03008 (October 2024); OIG Work Plan OAS-25-09-057What it means
- The money is concentrated. New York City and Long Island hold 67% of the state's Part A days. For-profit facilities hold 79%.
- The error runs both ways. A pharmacy that bills the facility after a Part A stay ends costs the owner money. A pharmacy that bills Part D during a Part A stay creates exposure. Both come from the same gap between the invoice and the census.
- It is checkable. Three files settle most questions: line-level invoices, a daily census with payer, and the pharmacy services agreement. Sections 8 and 9 give the checks.
The New York market
New York has 592 Medicare- or Medicaid-certified nursing homes with 111,253 certified beds and about 98,944 residents on an average day.
Certified beds
Average residents per day as a share of certified beds
Average beds per building (median 160)
Facilities by size
Number of New York nursing homes, by certified beds
Source: CMS Provider Information, October 2026 release. n = 592.
Ownership
Facilities by CMS ownership type
For-profit includes corporations, LLCs, partnerships and individuals. Government includes state, county and city. Source: CMS Provider Information, October 2026.
New York buildings are large. The average has 188 beds, well above the national average of about 107 reported by AHCA/NCAL. Larger buildings mean longer invoices, more admissions and discharges, and more boundary days where the payer changes.
38 facilities sit inside a hospital. Their drugs often run through the hospital pharmacy, so they are a different case.
Who runs New York nursing homes
CMS links facilities under common control into "affiliated entities", which we call chains. Half of New York's facilities have none. For those, we grouped buildings that share an owner in the CMS Ownership file. What remains are standalone homes: one building, no shared owner on record.
Chain affiliation
- In a CMS chain301 · 50.8%
- No chain, shared owner group112 · 18.9%
- Standalone179 · 30.2%
291 facilities (55,731 beds) have no CMS chain. They hold 43% of matched Part A days. Source: CMS Provider Information and Ownership files, October 2026; owner grouping by Pennywell.
Size of the operator behind each facility
Facilities, grouped by how many buildings their operator runs nationally
Operator = CMS chain where one exists, otherwise owner group or the standalone building. National building counts. 264 New York operators in all.
Why operator size matters. Large chains can afford a pharmacy contracts team, and some own their pharmacy. Operators with one to fifteen buildings usually do not. The business office pays the invoice, and nobody has time to match every line to the census. That is 69% of New York's facilities.
Caveat: owner grouping uses exact owner names in CMS data, which can merge two people with the same name or split one person spelled two ways. CMS ownership data can lag real transactions by months.
Where the Part A days are
In fiscal year 2024, Original Medicare paid New York nursing homes for 4,608,073 covered Part A days across 131,576 stays and 97,858 beneficiaries.
Medicare payments for those days, about $702 per day
Average covered days per stay
Of New York's Part A beneficiaries were dual-eligible for Medicaid
These counts cover Original Medicare only. Medicare Advantage stays are not in the file. Where an Advantage plan pays the facility a per diem that includes drugs, the facility carries drug cost for those days too, so the true number of facility-paid drug days is higher.
Payer mix of resident-days
All resident-days reported on New York cost reports
- Medicare (Title XVIII)13.8%
- Medicaid (Title XIX)63.7%
- Other payers22.5%
559 New York cost reports in the CMS SNF Cost Report file for 2023: 4.55 million Medicare days of 32.9 million total. "Other" includes Medicare Advantage, private pay and other insurers.
About one resident-day in seven is a Medicare day. That small share drives a large share of drug cost risk, because it is the share the facility pays for directly, and because short stays create the most boundary days: admissions, discharges, leaves and payer changes.
Part A days per facility
Number of facilities, by Original Medicare Part A days in fiscal year 2024
573 of 592 facilities matched to the CMS file by CCN. Median 4,895 days, about 13 Part A residents on an average day. Middle half: 2,620 to 10,916 days.
Part A days by region
Using New York's ten economic development regions, the Part A volume is heavily downstate. New York City alone accounts for 42% of matched Part A days.
Original Medicare Part A days, fiscal year 2024
Sum of facility-level days for the 573 matched facilities. Source: CMS PAC PUF, SNF by provider; regions from Empire State Development's Regional Economic Development Councils.
| Region | Facilities | Beds | Part A days | Drug spend (est.) | For-profit | No chain |
|---|---|---|---|---|---|---|
| New York City | 167 | 43,742 | 1,948,964 | $78.0M–$93.6M | 78% | 52% |
| Long Island | 77 | 15,898 | 1,134,328 | $45.4M–$54.4M | 83% | 47% |
| Mid-Hudson | 85 | 13,191 | 679,161 | $27.2M–$32.6M | 72% | 54% |
| Capital Region | 40 | 6,126 | 148,440 | $5.9M–$7.1M | 65% | 35% |
| Western New York | 56 | 8,148 | 144,558 | $5.8M–$6.9M | 68% | 34% |
| Central New York | 28 | 4,719 | 127,439 | $5.1M–$6.1M | 46% | 61% |
| Finger Lakes | 56 | 7,954 | 117,463 | $4.7M–$5.6M | 61% | 54% |
| Mohawk Valley | 32 | 4,505 | 115,728 | $4.6M–$5.6M | 62% | 56% |
| Southern Tier | 34 | 4,652 | 105,580 | $4.2M–$5.1M | 56% | 44% |
| North Country | 17 | 2,318 | 65,598 | $2.6M–$3.1M | 59% | 53% |
Pennywell estimate Drug spend column: Part A days × $40 to $48. Pennywell estimate; see section 4. The median facility had Part A days equal to about 10% of its resident-days, and 73 facilities were at a quarter or more (approximate: days are from fiscal year 2024, census from October 2026).
What Part A drugs cost New York facilities
No public dataset reports what each nursing home pays its pharmacy for Part A residents. So we estimate it, and show every input.
$184M to $221M a year
Pennywell estimate Facility-paid drug spend for Original Medicare Part A residents in New York nursing homes.
The method
| Input | Value | Source |
|---|---|---|
| Original Medicare Part A days, New York | 4,608,073 | CMS PAC PUF, fiscal year 2024 (public data) |
| Drug cost per Part A resident-day | $40–$48 | Range one SNF operator reported for 2017–2018 in Becker's Hospital Review. One operator, not a benchmark. Not adjusted for inflation. |
| Result | $184M–$221M | Days × cost per day |
| Share of Medicare SNF payments | 5.7%–6.8% | Result ÷ $3.23 billion Medicare payments (CMS PAC PUF) |
What it leaves out. Medicare Advantage days where the plan's per diem includes drugs. Drug price growth since 2018. Higher-acuity residents on costly therapies. Each of these would push the true figure up. What could push it down: buildings with lower drug intensity than the operator in the source.
How sensitive is it?
The cost per day is the assumption that matters. The table shows the result across a range. Our two anchor values are highlighted.
| Drug cost per Part A day | New York, per year | At 6%–12% disputable | Median facility, per year |
|---|---|---|---|
| $30 | $138M | $8.3M–$16.6M | $147k |
| $40 | $184M | $11.1M–$22.1M | $196k |
| $48 | $221M | $13.3M–$26.5M | $235k |
| $60 | $276M | $16.6M–$33.2M | $294k |
| $75 | $346M | $20.7M–$41.5M | $367k |
For one building
The median New York facility had 4,895 Part A days. At $40–$48 a day, that is roughly $196k to $235k a year in facility-paid Part A drugs, before Medicare Advantage. A facility at the 75th percentile is above $524k. Pennywell estimate
| New York facility | Part A days | Part A residents, avg. day | Drug spend (est.) | Disputable at 6%–12% (est.) |
|---|---|---|---|---|
| 25th percentile | 2,620 | 7 | $105k–$126k | $6k–$15k |
| Median | 4,895 | 13 | $196k–$235k | $12k–$28k |
| 75th percentile | 10,916 | 30 | $437k–$524k | $26k–$63k |
Percentiles of Original Medicare Part A days across 573 matched facilities, fiscal year 2024 (CMS PAC PUF). Spend and disputable columns are Pennywell estimates using the assumptions above.
Check the estimate against your own books
- Your Part A days. Your census or cost report (Worksheet S-3, Title XVIII days) gives the real count. Add Medicare Advantage days where the plan's per diem includes drugs.
- Your drug cost per Part A day. Divide twelve months of facility-paid pharmacy charges for Part A residents by Part A days. If it is far from $40–$48, use your own figure.
- Your exposure, not just your spend. Count the Part A days on which the pharmacy billed Part D instead of you. That number is not in any public file. It is in your invoices.
How much of it is disputable? We do not have audit results to report. Our working assumption, used in our savings calculator, is that 6% to 12% of facility-paid drug spend is disputable on a typical unaudited invoice. Applied to New York, that is $11M to $27M a year, or about $12k to $28k for the median building. Treat it as a hypothesis to test on your own invoices, not a finding.
The rules
For a covered Part A day, drugs are inside Medicare's daily rate. The pharmacy should bill the facility. Not Part D, not Medicaid, not the family.
Consolidated billing
Under the SNF prospective payment system, Medicare pays a per diem for each covered Part A day. Consolidated billing makes the facility responsible for nearly all services its Part A residents receive, including those furnished by outside suppliers such as the pharmacy. The rule sits at 42 CFR 411.15(p). CMS states the consequence plainly: drugs for a Part D enrollee are not covered by Part D if Part A or Part B can pay for them.
The facility also carries the underlying duty. Federal participation rules at 42 CFR 483.45 require every nursing home to provide pharmaceutical services. The facility holds the source of truth for payer status: admission, discharge, leave and benefit dates.
The exclusions
A defined set of services sits outside the bundle and is billed separately. CMS publishes them annually by HCPCS code, in five major categories. The ones that matter for pharmacy:
Certain chemotherapy (Category III)
Only the listed codes. Anti-emetics and other supportive drugs stay inside the bundle. A listed drug used for a non-cancer purpose is not excluded.
ESRD dialysis-related drugs (Category II)
ESAs such as epoetin alfa given with dialysis by the dialysis facility. They should not also appear on the pharmacy invoice.
Hospice-related drugs (Category II)
Drugs for the terminal illness are the hospice's responsibility under its own benefit.
Covered vaccines and others (Categories III–IV)
Pneumococcal, influenza, hepatitis B and COVID-19 vaccines, radioisotopes and certain blood clotting factors.
The lists change. Beginning January 2026 CMS stopped listing some categories' codes in the Part A file and points to other CMS lists instead. Check the current year's files, not last year's spreadsheet.
Discharge, death and leave of absence
- Day of discharge or death. Generally not a covered utilization day. Ancillary charges for that day are built into the PPS rate and cannot be billed separately (Medicare Claims Processing Manual, Ch. 6, §40.3.5).
- Leave of absence. The day a resident begins a leave is generally not counted as a utilization day. Leave days are reported on the claim with zero charges (Ch. 6, §40.3.5 and §40.3.5.2). Who pays for drugs sent with the resident depends on coverage and contract. It should not default to the facility.
- Take-home supply. Part A covers a limited supply for use outside the facility when medically necessary to help the resident leave, until a continuing supply can be obtained. A full cycle fill dated after discharge is not that.
Where the line blurs: the boundary days
Most errors happen at the edges of a stay, not in the middle. Use this table to test the dates on your invoice.
| Situation | Who generally pays for the drug | What to check on the invoice |
|---|---|---|
| Covered Part A day | The facility, inside the per diem | No Part D or Medicaid claims for that resident that day |
| Day of Part A admission | The facility | The pharmacy's payer flag switched on the admission date, not days later |
| Day of discharge | Built into the PPS rate for prior covered days | No separate claim for drugs given that day before discharge |
| Take-home supply at discharge | Part A, when medically necessary until a continuing supply is available | Quantity limited, documented, billed once |
| Part A ends, resident stays | Part D, Medicaid or the resident, depending on coverage | Payer flag switched on the right date, so the facility stops paying |
| Leave of absence past midnight | Not a covered Part A day | Whether the facility was billed for drugs sent on leave |
| Hospital transfer | Not the facility, for days the resident is out | No cycle fills delivered during the hospital stay |
| Medicare Advantage resident | The plan's contract with the facility governs | Whether drugs are inside the plan per diem or carved out |
| Excluded drug (for example, listed chemotherapy) | Billed outside the Part A rate | The facility was not billed for it |
| Hospice election | The hospice, for drugs related to the terminal illness | Hospice-related drugs are not on the facility invoice |
Two directions of error. When the pharmacy keeps billing Part D after a Part A admission, the facility's bill looks lower than it should and compliance exposure grows quietly. When the pharmacy keeps billing the facility after a Part A stay ends, the facility overpays. Both come from one root cause: the pharmacy's view of payer status does not match the census.
Sources: 42 CFR 411.15(p); 42 CFR 483.45; CMS SNF consolidated billing page and 2026 general explanation of major categories; Medicare Claims Processing Manual Ch. 6; CMS MLN fast facts on improper Part D payments; AHCA/NCAL summary of CMS's May 2025 SNF Billing Reference update. Full links in section 11.
The risk
The OIG has already measured what Part D paid for drugs that belonged to the Part A stay. Its next project looks at the facilities.
Up to this much in Part D total cost, 2018–2020, for drugs for which payment was available under the Part A SNF benefit.
Of that, drugs that SNF medical records showed were administered during the Part A stay.
HHS OIG audit A-09-21-03008, issued October 2024. National figures.
Timeline
- October 2024OIG audit A-09-21-03008. Estimates up to $465.1M in improper Part D payments for 2018–2020. Notes that some drugs given during Part A stays were supplied by residents or families, though the facility was responsible. CMS concurred with all five recommendations.
- April 2025OIG Work Plan project OAS-25-09-057 opens. "SNFs' Financial Responsibility for Drugs for Medicare Part D Enrollees in Part A SNF Stays." It will audit whether facilities met federal requirements, and why some obtained drugs from enrollees or families. Status: active.
- May 2025CMS updates its SNF Billing Reference to address where drug claims go during short and long stays, as AHCA/NCAL summarized for members.
- June 2025OIG marks the recommendation that CMS instruct SNFs to cooperate with plan sponsors as implemented.
What this means for a New York operator
- Plan sponsors and CMS now have more reason to ask facilities for stay dates and administration records. Keep them ready.
- Accepting drugs from families during a Part A stay is a named concern. Stop it if it happens.
- A clean census-to-invoice reconciliation each month is the evidence that you meet your obligation.
We report what the OIG and CMS have published. We do not predict audit selection or outcomes, and this is not legal advice.
What overbilling looks like
These are categories, not rates. We publish no error frequencies because we have no audit data to support them yet. Each category below follows from the rules in section 5 and the mechanics of long-term care dispensing.
Payer misbilling
Lines billed to the facility for residents who were Medicaid, private pay or hospice on that date. Usually a payer flag that changed late or never.
Charges after discharge, death or leave
Cycle fills built from an active list a few days behind the census. Fills delivered during a hospital stay. Leave medications billed to the facility by default.
Duplicates
Same drug, same resident, same date, billed twice. A new fill while the last still had days of supply. A refill billed on two invoices.
Missing credits
Returns from discontinued orders, discharges and deaths that were never credited, credited at less than full value, or promised and never posted.
Fees outside the contract
Dispensing, delivery, STAT, e-kit, packaging and IV fees that the agreement does not list, or charged more often than it allows.
Excluded items billed to the facility
Listed chemotherapy, dialysis-related ESAs, hospice-related drugs or covered vaccines on the facility's Part A invoice.
Price above the contract formula
A different reference price, the wrong date, a more expensive package size than the NDC dispensed, or a generic far above public benchmarks.
The reverse: exposure, not overpayment
Drugs billed to Part D during a covered Part A stay, or supplied by the family. The invoice looks cheaper. The compliance risk is higher. This is the pattern the OIG measured.
An illustrative line. Not from any real invoice. A resident's Part A stay ends March 6; from March 7 the census shows Medicaid. On March 9 the pharmacy bills the facility for a 14-day brand anticoagulant fill, with a STAT delivery fee and no STAT order. A 14-day fill was also dispensed February 28. One line, three questions: wrong payer, overlapping supply, unsupported fee.
The 20-point invoice checklist
Run it on three months of line-level invoices, a daily census with payer, and your pharmacy services agreement. One month hides late credits and repeated charges.
Payer and census
Or another arrangement where you pay, such as an Advantage per diem that includes drugs.
Those drugs belong on someone else's bill.
Days of Part D billing at the start of a stay are exposure, not savings.
Every lagged day is a day you pay for drugs you no longer owe.
Read each contract. Not every plan follows original Medicare's structure.
Exits and absences
Compare every exit date to every later line for that resident.
Check transfer and return dates against delivery dates.
Not to the facility by default.
Match quantity to the discharge order.
Duplicates and credits
Sort by resident, NDC and date. Repeated Rx numbers are a signal.
Also look for a brand and its generic in the same period.
Discontinued orders, discharges and deaths. Keep a return log.
Track credits as receivables until they arrive.
Fees
Check whether short dispensing cycles multiply the fee.
Each STAT fee should trace to a STAT request.
Doses pulled from the kit at contract price, not a higher kit price.
Pump rental stops when therapy stops. No packaging fee where packaging is included in price.
Exclusions and price
Listed chemotherapy, dialysis-related ESAs, hospice-related drugs, covered vaccines. Use the current year's CMS files.
For the NDC dispensed, on the dispense date, using the named reference.
CMS's National Average Drug Acquisition Cost is not your contract price, but a wide gap deserves a written answer.
How often
| Cadence | Checks |
|---|---|
| Every invoice | 1–9, on all Part A residents and all exits |
| Monthly | 10–17 |
| Quarterly | 18–20, on the top 50 drugs by spend |
| At renewal | All 20, against twelve months of invoices |
Ten contract terms to check
The pharmacy services agreement decides most of the bill before a single drug is dispensed. For Part A residents it is a cost contract, and every term below hits that line.
1Brand pricing formula
Which reference (AWP or WAC), which date, which package.
Strong: named reference, dispense-date price, NDC dispensed.2Generic pricing formula
A MAC list you cannot see is a price you cannot audit.
Strong: visible MAC list and a "lesser of" rule.3Per diem and true-up
What is inside the per diem, what is billed on top, and who counts the days.
Strong: clear inclusions, census-based day count.4Dispensing fees
Whether they apply to facility-paid drugs at all, and per fill, card or dose.
Strong: stated amount and trigger.5Delivery, STAT and after-hours
Routine trips included, what qualifies as STAT, per trip or per item.
Strong: listed amounts, defined triggers.6Emergency kit
Kit fee, restocking fee, price of doses pulled, expired contents.
Strong: kit doses at contract price.7IV therapy
Per diem, pump rental, supplies and compounding, each defined.
Strong: rental ends when therapy ends.8Credits and returns
What is creditable, at what value, by when, and who picks up.
Strong: defined, time-bound, shown on invoice.9Payer classification
Who decides the payer each day, and what happens when it is wrong.
Strong: stated duties and a correction process.10Dispute window, audit rights, renewal
Days to dispute, right to line-level data, auto-renewal and mid-term price changes.
Strong: 60–90+ day window and line-level audit rights.Before your next renewal, read the agreement against twelve months of invoices. The gap between what the contract says and what you were billed is your negotiating position. For an operator with several buildings on one agreement, that position multiplies.
"Strong" reflects our view of terms that make an invoice auditable. It is not legal advice. Contract decisions should involve your counsel.
A 90-day plan
You do not need new software to start. You need a reliable loop between census and pharmacy, and someone who owns it.
Days 1–30
- Pull the agreement and every amendment. Note the dispute window.
- Ask the pharmacy for line-level invoices for the last three months.
- Name one person to send admissions, discharges, payer changes and leaves to the pharmacy the same day.
Days 31–60
- Run checks 1–9 on every Part A resident and every exit.
- Ask for the pharmacy's list of residents flagged Part A last month, with dates. Compare to census.
- Start a return log and a credits-due list.
Days 61–90
- Run checks 10–20.
- Send disputes in writing, inside the window: invoice line, census record, contract clause.
- List contract terms to fix at renewal.
Questions to ask your pharmacy this month
- How do you receive our admissions, discharges, payer changes and leaves, and how fast do you apply them?
- Can you send a monthly list of residents you flagged as Part A, with start and end dates?
- How do you handle claims billed to Part D that turned out to fall inside a Part A stay?
- When a cycle fill goes out for a resident who has left, what triggers the credit, and how long does it take?
- How do you identify drugs excluded from consolidated billing?
- Can you send a monthly list of credits issued, by resident and original charge?
If the answers are vague, the reconciliation is probably not happening on either side.
Methodology and sources
Data
- Facilities. CMS Provider Information and Ownership files, October 2026 release. All 592 New York nursing homes in the file. Beds are certified beds; residents are CMS's average residents per day. Ownership groups follow CMS's ownership type field.
- Operators. CMS chain (affiliated entity) where present. Otherwise, facilities sharing an owner with an ownership interest in the Ownership file were grouped (exact name match). Remaining facilities are standalone. Operator size is the national building count.
- Part A days. CMS Medicare Post-Acute Care Utilization, SNF by Geography and Provider, fiscal year 2024. TOT_SRVC_DAYS = Medicare covered days on Original Medicare SNF claims. Statewide total 4,608,073. 573 facilities matched by CCN (4,587,259 days); 19 did not match, mainly facilities with no Original Medicare SNF claims in the year or that opened, closed or changed CCN. Medicare Advantage is not included.
- Payer mix. CMS SNF Cost Report public use file, 2023: Title XVIII, Title XIX and total days across 559 New York reports. Cost reporting periods vary by facility.
- Regions. New York's ten Regional Economic Development Council regions, mapped by county.
Estimates and assumptions Pennywell estimate
- Drug cost per Original Medicare Part A day: $40 low, $48 high. The range one SNF operator reported for 2017 and 2018 in Becker's Hospital Review. Not a statewide benchmark. Not inflated.
- Disputable share of facility-paid drug spend: 6% to 12%. Our working assumption, also used in our savings calculator. Not a measured result.
- Part A share of resident-days per facility compares fiscal year 2024 days to October 2026 average census. Approximate.
- No figure in this report comes from client data. We have none to report.
Sources
- CMS, Provider Information dataset (4pq5-n9py). https://data.cms.gov/provider-data/dataset/4pq5-n9py
- CMS, Ownership dataset (y2hd-n93e). https://data.cms.gov/provider-data/dataset/y2hd-n93e
- CMS, Medicare Post-Acute Care Utilization: SNF by Geography and Provider, and RY2026 methodology. https://data.cms.gov/provider-summary-by-type-of-service/medicare-post-acute-care-hospice/medicare-post-acute-care-utilization-skilled-nursing-facility-by-geography-and-provider
- CMS, Skilled Nursing Facility Cost Report public use file. https://data.cms.gov/provider-compliance/cost-reports/skilled-nursing-facility-cost-report
- HHS OIG, Medicare Part D Paid Millions for Drugs for Which Payment Was Available Under the Medicare Part A SNF Benefit, A-09-21-03008 (October 2024). https://oig.hhs.gov/reports/all/2024/medicare-part-d-paid-millions-for-drugs-for-which-payment-was-available-under-the-medicare-part-a-skilled-nursing-facility-benefit
- HHS OIG Work Plan, SNFs' Financial Responsibility for Drugs for Medicare Part D Enrollees in Part A SNF Stays, OAS-25-09-057. https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/snfs-financial-responsibility-for-drugs-for-medicare-part-d-enrollees-in-part-a-snf-stays
- 42 CFR 411.15(p), consolidated billing. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-411/subpart-A/section-411.15
- 42 CFR 483.45, pharmacy services. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-483/subpart-B/section-483.45
- 42 CFR 423.154, LTC dispensing and returned drugs. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-B/part-423/subpart-C/section-423.154
- CMS, SNF consolidated billing. https://www.cms.gov/medicare/coding-billing/skilled-nursing-facility-snf-consolidated-billing
- CMS, 2026 general explanation of the major categories for SNF consolidated billing. https://www.cms.gov/files/document/2026-general-explanation-major-categories-skilled-nursing-facility-snf-consolidated-billing-cb.pdf
- CMS, Medicare Claims Processing Manual, Chapter 6, §40.3.5 and §40.3.5.2. https://www.cms.gov/Regulations-and-guidance/Guidance/Manuals/Downloads/clm104c06.pdf
- CMS MLN, SNFs: identify and prevent improper Part D payments for drugs. https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/fast-facts/skilled-nursing-facilities-identify-prevent-improper-part-d-payments-drugs
- AHCA/NCAL, CMS updates SNF billing guidance related to Part D drug coverage (2025). https://www.ahcancal.org/News-and-Communications/Blog/Pages/CMS-Updates-SNF-Billing-Guidance-Related-to-Part-D-Drug-Coverage.aspx
- LeadingAge New York, temporary leaves and Medicare SNF coverage. https://leadingageny.org/providers/nursing-homes/reimbursement1/medicare/temporary-leaves-and-medicare-snf-coverage/
- Becker's Hospital Review, Drug costs put squeeze on skilled nursing facilities. https://www.beckershospitalreview.com/pharmacy/drug-costs-put-squeeze-on-skilled-nursing-facilities/
- CMS / Medicaid.gov, National Average Drug Acquisition Cost (NADAC). https://data.medicaid.gov/dataset/99315a95-37ac-4eee-946a-3c523b4c481e
- AHCA/NCAL, Fast Facts (national nursing home count and average size). https://www.ahcancal.org/News-and-Communications/Fact-Sheets/FastFacts/Pages/default.aspx
- New York State, Regional Economic Development Councils. https://regionalcouncils.ny.gov/
Links checked November 2026. Data and scripts: available on request.
About Pennywell
Pennywell checks a nursing home's pharmacy invoices against its census, its pharmacy services agreement and market prices, then shows the operator exactly where they overpay, with dispute-ready evidence, in 48 hours.
Independent
We take no money from pharmacies or manufacturers. Published, flat pricing.
No percentage
We do not collect recoveries or take a share. You dispute using our package.
Easy start
Three files, no system integration. A BAA is signed before any data moves.
Test the estimate on your own invoices
Send three months of pharmacy invoices, your census and your pharmacy services agreement. Within 48 hours we show you where payer status, dates, fees and credits on the invoice do not match, line by line. The first look is free.
www.pennywellhealth.com/free-audit · www.pennywellhealth.com/savings-calculator
| Step | What you get | Price |
|---|---|---|
| Free 48-hour first look | A report on three months of invoices showing exposure and overbilling | Free |
| Full audit | A dispute package for each finding: invoice lines, census evidence, contract clause, draft dispute letter | $5,000 per building |
| Monthly monitoring | Every invoice checked, and confirmation that credits arrived | $1,000 per building per month |
The full-audit fee is waived on multi-building monitoring contracts.
© 2026 Pennywell. General information, not legal or billing advice. Facilities make their own compliance and dispute decisions. Figures labeled "Pennywell estimate" are estimates built from public inputs and stated assumptions, not audit results. This report names no facility, owner or resident.